Catalent to double biomanufacturing capacity with $200m investment
Catalent will use the funds to enlarge drug substance manufacturing and drug product fill/finish capacity.
Archives for January 10, 2019
‘An incredible opportunity’: Takeda signs immuno-oncology collaborations
Takeda entered multiple research collaborations for immuno-oncology and CAR-T therapies, an area of strategic focus for the company.
Novartis knocked back by UK on first-in-class migraine treatment
Novartis' treatment for migraines is rejected by NICE on cost-effectiveness grounds, and lack of long-term data.